D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$365M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$307M |
| 3 |
Adobe
ADBE
|
+$250M |
| 4 |
NVIDIA
NVDA
|
+$242M |
| 5 |
Salesforce
CRM
|
+$240M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PayPal
PYPL
|
+$520M |
| 2 |
ExxonMobil
XOM
|
+$372M |
| 3 |
Bank of America
BAC
|
+$271M |
| 4 |
Netflix
NFLX
|
+$172M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$171M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.14% |
| 2 | Financials | 9.37% |
| 3 | Healthcare | 7.49% |
| 4 | Consumer Discretionary | 6.79% |
| 5 | Communication Services | 4.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GWII
976
DELISTED
Good Works II Acquisition Corp. Common Stock
GWII
| $14.3M | 0.02% |
1,429,271
+1,018
| +0.1% | +$10.2K |
|
977
Conagra Brands
CAG
$6.94B
| $14.3M | 0.02% |
437,987
-47,507
| -10% | -$1.63M |
|
978
Sensata Technologies
ST
$6.74B
| $14.3M | 0.02% |
382,810
+316,193
| +475% | +$13.2M |
|
979
Box
BOX
$4.37B
| $14.2M | 0.02% |
582,709
+150,191
| +35% | +$4.13M |
|
980
ADMA Biologics
ADMA
$1.96B
| $14.2M | 0.02% |
5,843,796
+1,011,404
| +21% | +$2.43M |
|
|
EQC
981
DELISTED
Equity Commonwealth
EQC
| $14.2M | 0.02% |
581,521
-124,996
| -18% | -$3.36M |
|
982
PUT
BioNTech
BNTX
$22.9B
| $14.2M | 0.02% |
105,000
-33,100
| -24% | -$5.06M |
|
|
HCAR
983
DELISTED
Healthcare Services Acquisition Corporation Class A Common Stock
HCAR
| $14.2M | 0.02% |
1,423,957
+400,000
| +39% | +$3.96M |
|
984
Huazhu Hotels Group
HTHT
$13.1B
| $14.1M | 0.02% |
421,107
+295,888
| +236% | +$11.2M |
|
|
HOLX
985
DELISTED
Hologic
HOLX
| $14.1M | 0.02% |
218,515
-10,687
| -5% | -$740K |
|
986
Community Health Systems
CYH
$393M
| $14.1M | 0.02% |
6,553,263
+1,927,198
| +42% | +$6.38M |
|
|
NOVA
987
DELISTED
Sunnova Energy
NOVA
| $14M | 0.02% |
635,233
+374,685
| +144% | +$9.09M |
|
988
CALL
DoorDash
DASH
$85.5B
| $14M | 0.02% |
283,500
+64,100
| +29% | +$4.28M |
|
989
CALL
Archer Daniels Midland
ADM
$38.2B
| $14M | 0.02% |
174,200
+59,000
| +51% | +$4.86M |
|
990
Toast
TOST
$18.7B
| $14M | 0.02% |
837,193
-422,529
| -34% | -$7.33M |
|
991
Alcoa
AA
$11.9B
| $14M | 0.02% |
415,362
-522,313
| -56% | -$24.4M |
|
992
CALL
Air Products & Chemicals
APD
$65.7B
| $14M | 0.02% |
60,000
-10,000
| -14% | -$2.48M |
|
993
CALL
Cheniere Energy
LNG
$55.2B
| $13.9M | 0.02% |
+84,000
| New | +$12.7M |
|
994
PUT
Zillow
Z
$7.79B
| $13.9M | 0.02% |
487,000
+104,400
| +27% | +$3.62M |
|
995
Teradata
TDC
$2.92B
| $13.9M | 0.02% |
448,347
+235,738
| +111% | +$8.24M |
|
996
PUT
Dillards
DDS
$9.19B
| $13.9M | 0.02% |
50,800
+6,900
| +16% | +$1.83M |
|
997
West Pharmaceutical
WST
$24B
| $13.8M | 0.02% |
56,126
-27,887
| -33% | -$8.5M |
|
|
AVAN
998
DELISTED
Avanti Acquisition Corp.
AVAN
| $13.8M | 0.02% |
1,377,110
+15,611
| +1% | +$156K |
|
999
Atlassian
TEAM
$25.6B
| $13.8M | 0.02% |
65,386
-454,117
| -87% | -$106M |
|
1000
CALL
Moderna
MRNA
$21.8B
| $13.8M | 0.02% |
116,300
-208,900
| -64% | -$31.7M |
|
Similar funds
D.E. Shaw & Co's Q3 2022 Portfolio in Review
As of Q3 2022, D.E. Shaw & Co held 5,820 positions worth $83.7B, down 1.8% from $85.3B the previous quarter. Its ten largest holdings account for 8.7% of the portfolio.
D.E. Shaw & Co withdrew a net $3.66B in Q3 2022, closing 679 positions and reducing 1,597 holdings. Its most notable exit was iShares MSCI Emerging Markets ETF, an estimated $171M position sold in full.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.
Against the trend, D.E. Shaw & Co opened a new position in Prologis worth $66.1M.
- D.E. Shaw & Co's largest Q3 2022 buy was Prologis: 650,725 shares worth $66.1M.
- D.E. Shaw & Co added most to Visa in Q3 2022, an estimated $365M increase.
- D.E. Shaw & Co's biggest Q3 2022 reduction was PayPal, cutting an estimated $520M.
- D.E. Shaw & Co fully exited iShares MSCI Emerging Markets ETF in Q3 2022, selling an estimated $171M.
- D.E. Shaw & Co's ten largest holdings make up 8.7% of its $83.7B portfolio in Q3 2022.
- D.E. Shaw & Co opened 545 new positions and closed 679 in Q3 2022.
- D.E. Shaw & Co's portfolio value fell 1.8% quarter-over-quarter to $83.7B.
Based on D.E. Shaw & Co's 13F filing for Q3 2022, filed 14 Nov 2022.